DEVELOPMENT OF ERECTILE DYSFUNCTION IN MEN TREATED FOR MAJOR DEPRESSIVE DISORDER WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS: A SYSTEMATIC REVIEW

被引:0
|
作者
Alhuwaydi, A. [1 ]
机构
[1] Jouf Univ, Sakakah, Saudi Arabia
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
456
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine and venlafaxine, in Korean patients with major depressive disorder
    Jung, Y. -E.
    Jun, T. -Y.
    Kim, K. -S.
    Bahk, W. -M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (07) : 437 - 443
  • [32] Selective Serotonin Reuptake Inhibitors for Cessation of Betel Quid Use in Patients with Major Depressive Disorder in Taiwan
    Hung, Chung-Chieh
    Tu, Hung-Pin
    Chung, Chia-Min
    BIOMEDICINES, 2024, 12 (11)
  • [33] Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder
    Krupa, Anna J.
    Chrobak, Adrian A.
    Soltys, Zbigniew
    Dudek, Dominika
    Szewczyk, Bernadeta
    Siwek, Marcin
    PHARMACOLOGICAL REPORTS, 2024, 76 (05) : 1100 - 1113
  • [34] Evaluation of the effect of selective serotonin-reuptake inhibitors on lymphocyte subsets in patients with a major depressive disorder
    Eugenia Hernandez, Maria
    Martinez-Fong, Daniel
    Perez-Tapia, Mayra
    Estrada-Garcia, Iris
    Estrada-Parra, Sergio
    Pavon, Lenin
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 (02) : 88 - 95
  • [35] Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors
    Cooper-Kazaz, Rena
    Lerer, Bernard
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (05): : 685 - 699
  • [36] Resolution of sleepiness and fatigue in the treatment of major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors
    Papakostas, GI
    Nutt, DJ
    Tucker, VL
    Krishen, A
    Fava, M
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S186 - S187
  • [37] Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder
    Ramesh, Varsha
    Venkatesan, Vettriselvi
    Ramasamy, Balakrishnan
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (04)
  • [38] Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
    Janus Christian Jakobsen
    Kiran Kumar Katakam
    Anne Schou
    Signe Gade Hellmuth
    Sandra Elkjær Stallknecht
    Katja Leth-Møller
    Maria Iversen
    Marianne Bjørnø Banke
    Iggiannguaq Juhl Petersen
    Sarah Louise Klingenberg
    Jesper Krogh
    Sebastian Elgaard Ebert
    Anne Timm
    Jane Lindschou
    Christian Gluud
    BMC Psychiatry, 17
  • [39] Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
    Jakobsen, Janus Christian
    Katakam, Kiran Kumar
    Schou, Anne
    Hellmuth, Signe Gade
    Stallknecht, Sandra Elkjaer
    Leth-Moller, Katja
    Iversen, Maria
    Banke, Marianne Bjorno
    Petersen, Iggiannguaq Juhl
    Klingenberg, Sarah Louise
    Krogh, Jesper
    Ebert, Sebastian Elgaard
    Timm, Anne
    Lindschou, Jane
    Gluud, Christian
    BMC PSYCHIATRY, 2017, 17
  • [40] Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review
    Tarchi, Livio
    Merola, Giuseppe Pierpaolo
    Baccaredda-Boy, Ottone
    Arganini, Francesca
    Cassioli, Emanuele
    Rossi, Eleonora
    Maggi, Mario
    Baldwin, David S.
    Ricca, Valdo
    Castellini, Giovanni
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (10) : 1053 - 1067